Choleretic activities of 1-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-1, 2, 3, 4-tetrahydro quinazoline hydrochloride (HQ-275).
D000438:Alcohols / Q000494:pharmacology; D014670:Ampulla of Vater / Q000187:drug effects; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002252:Carbon Tetrachloride Poisoning / Q000188:drug therapy; D002756:Cholagogues and Choleretics; D002784:Cholesterol / Q000097:blood; D003510:Cyclohexanes / Q000494:pharmacology; D003685:Dehydrocholic Acid / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D009025:Morpholines / Q000494:pharmacology* / Q000633:toxicity; D009119:Muscle Contraction / Q000187:drug effects; D011799:Quinazolines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012119:Respiration / Q000187:drug effects
D000438:Alcohols; D000893:Anti-Inflammatory Agents; D002756:Cholagogues and Choleretics; D003510:Cyclohexanes; D009025:Morpholines; D011799:Quinazolines; D002784:Cholesterol; D003685:Dehydrocholic Acid